This topic contains a solution. Click here to go to the answer

Author Question: Why are bays and estuaries especially sensitive to pollution? A) The water is stagnant. B) Fresh ... (Read 47 times)

vicky

  • Hero Member
  • *****
  • Posts: 586
Why are bays and estuaries especially sensitive to pollution?
 A) The water is stagnant.
  B) Fresh water can be polluted more easily.
  C) Few bacteria are present to aid with biodegradation of pollutants.
  D) Pollution flows out with river water or is released directly by industry in busy ports.

Question 2

Chlorinated hydrocarbons are ____.
 A) toxic compounds used in pesticides and industrial solvents that cause problems in some areas of the ocean
  B) created by chemosynthetic bacteria in the ocean
  C) a physical resource extracted along with petroleum
  D) important nutrients for some species of phytoplankton



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jrpg123456

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

D

Answer to Question 2

A





 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library